MAP PHARMACEUTICALS, INC. Deferred Revenue
MAP PHARMACEUTICALS, INC. had Deferred Revenue of $60.00 million as of 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2012-11-06
- 2012-09-30: Deferred Revenue $60.00M.
- 2012-06-30: Deferred Revenue $60.00M.
| Period end | Deferred Revenue |
|---|---|
| 2012-09-30 | $60.00M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $60.00M 10-Q · filed 2012-07-27 |